Non-pharmacological management of type 2 diabetes

Acta Clinica Belgica

Volumn 59, Issue 1, 2004, Pages 14-19

  Buysschaert, M ^a   Hermans, M P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Diet; Exercise; Lifestyle; Type 2 diabetes

Indexed keywords

CALORIC INTAKE; EXERCISE; GLUCOSE HOMEOSTASIS; HIGH FIBER DIET; HUMAN; LIFESTYLE; LOW FAT DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; SMOKING CESSATION;

EID: 1542284219     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2004.002     Document Type: Review

References (40)

1. Buysschaert M. Diabétologie clinique. Louvain-la-Neuve, Paris: De Boeck Université 2e eds. 2001.
2. Buysschaert M, Vandenbroucke C, Barsoum S. A type 2 diabetes screening program by general practioners in a belgian at risk population. Diabetes Metab (Paris). 2001; 27: 109-14.
3. Sinha R, Fisch G, Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002; 346: 802-10.
4. King H, Aubert R, Herman W. Global burden of diabetes, 1995-2025; prevalence, numerical estimates and projections. Diabetes Care. 1998; 21: 1414-31.
5. Buysschaert M, Hermans M. Glycaemic and blood pressure controls achieved in a cohort of 318 patients with type 2 diabetes. Acta Clin Belg. 1999; 54: 328-33.
6. Kannel N, Mc Gee D. Diabetes and cardiovascular disease: the Framingham study. JAMA. 1979; 241: 2035-38.
7. Manson J, Colditz G, Stampfer M et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Int Med. 1991; 151: 1141-47.
8. Gaede P, Vedel P, Larsen N, Jensen G, Parving H-H, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003; 348: 383-93.
9. United Kingdom Prospective Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 847-53.
10. United Kingdom Prospective Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352: 854-65.
11. Helmrich S, Ragland D, Leung R, Paffenbarger R. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med. 1991; 325: 147-52.
12. Hu F, Sigal R, Rich-Edwards J et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA. 1999; 282: 1433-39.
13. Pan X, Li G, Hu Y, Sol S. Effects of diet and exercice in preventing NIDDM in people with impaired glucose tolerance. The DaQuing IGT and Diabetes study. Diabetes Care. 1997; 20: 537-44.
14. Tuomilehto J, Lindström J, Eriksson J et al. for the finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344: 1343-50.
15. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle interventions or metformin. N Engl J Med. 2002; 346: 393-03.
16. Boule N, Haddad E, Kenny G, Wells G, Sigal R. Effects of exercice on glycaemic control and body mass in type 2 diabetes mellitus. A metaanalysis of controlled clinical trials. JAMA. 2001; 286: 1218-27.
17. Sigal R, Kenny G, Koivisto V. In: Textbook of Diabetes 1, edited by JC Pickup, Williams G. Exercice and diabetes mellitus. London: Blackwell Science 3e eds: 37.1-37.19.
18. Wei M, Kampert J, Barlow C et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight and obese men. JAMA. 1999; 282: 1547-51.
19. Wei M, Gibbons L, Kampert J, Nichaman M, Blair S. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Int Med. 2000; 132: 605-11.
20. Hu F, Stampfer M, Solomon et al. Physical activity and risk for cardiovascular events in diabetic women. Ann Int Med. 2001; 134: 96-05.
21. Koivisto V, Soman V, Defronzo R, Felig P. Effects of acute exercise and training on insulin binding to monocytes and insulin sensitivity in vivo. Acta Paediatr Scan Suppl. 1980; 283: 70-8.
22. Nygard O, Vollset S, Refsum H, Brattstrom L, Ueland P. Total homocysteine and cardiovascular disease. J Intern Med. 1999; 246: 425-54.
23. US Department of Health and Human Services: Physical Activity and Health: A report of the Surgeon General Centers for Disease Control and Prevention, National Centers for Chronic disease Prevention and Health Promotion. Washington DC, US Govt Printing Office. 1996.
24. American Diabetes Association. Physical activity / exercice and diabetes mellitus. Diabetes Care. 2003; 26 suppl. 1: S73-S77.
25. Kimm S, Glynn N, Kriska A, Barton B, Kronsberg S, Daniels S et al. Decline in physical activity in black girls and white girls during adolescence. N Engl J Med. 2002; 347: 709-15.
26. Hamdy O, Ledbury S, Mullooly C et al. Lifestyle modifications improve endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003; 26: 2119-25.
27. Hu F, Manson J. In: Textbook of Diabetes 1, edited by JC Pickup, Williams G. Management of diabetes: diet and lifestyle modification. London: Blackwell Science 3e eds: 36.1-36.13.
28. American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2003; 26 suppl. 1: S51-S61.
29. Jimenez-Cruz A, Bacardi-Gascon M, Turnbull W, Rosales-Garay P, Severino-Lugo I. A flexible, low-glycaemic index mexican-style diet in overweight and obese subjects with type 2 diabetes improves metabolic parameters during a 6-week treatment period. Diabetes Care. 2003; 26: 1967-70.
30. Buysschaert M, Dramaix AS, Wallemacq P, Hermans M. Hyperhomocysteinemia in type 2 diabetes. Relationship to macroangiopathy, nephropathy and insulin resistance. Diabetes Care. 2000; 23: 1816-22.
31. Buysschaert M, Hermans M. In: Journées Annuelles de Diabétologie Hôtel Dieu. Comment je traite et prends en charge une hyperhomocystéinémie. Paris: Flammarion Médecine Sciences. 2003: 229-37.
32. Buysschaert M, Hermans M. L'homocystéinémie: un marqueur essentiel en pathologie endocrinienne aussi. In: Mises au point Cliniques d'Endocrinologie, Nutrition et Métabolisme. Paris. 2003: pages 165-180.
33. Malinow M, Duell P, Hess D et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med. 1998; 338: 1009-15.
34. Haubursin C, Buysschaert M. Apports nutritionnels de patients diabétiques de type 1 et 2 belges. Acta Clin Belg. 2001; 56: 91-5.
35. Deckers S, Hermans M, Buysschaert M. Therapy, glycaemic control and complications in type 1 diabetic patients: results from a single centre cohort of 465 subjects. Acta Clin Belg. 2001; 56: 289-96.
36. American Diabetes Association. Smoking and diabetes. Diabetes Care. 1993; 26 suppl. 1: S89-S90.
37. Turner R, Cull L, Frighi V, Holman R for the United Kingdom Prospective Study (UKPDS) Group. Glycaemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49). JAMA. 1999; 281: 2005-12.
38. Slama G. In: Journées Annuelles de Diabétologie Hôtel Dieu. Pourquoi il faut tendre vers une polychimiothérapie systématique précoce chez les diabétiques de type 2. Paris: Flammarion Médecine-Sciences. 2001: 219-28.
39. Preumont V, Buysschaert M. Nouvelles approches dans le traitement du diabète de type 2. Louvain Med. 2002; 121: 31-7.
40. UKPDS 13. Relative efficacy of randomized allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non insulin-dependent diabetes followed for three years. Br Med J. 1995; 310: 83-8.